Standout Papers

Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders 2005 2026 2012 2019 2.5k
  1. Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders (2005)
    E. Joanna Baxter, Linda M. Scott et al. The Lancet
  2. Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders (2005)
    E. Joanna Baxter, Linda M. Scott et al. The Lancet

Immediate Impact

3 by Nobel laureates 29 from Science/Nature 90 standout
Sub-graph 1 of 19

Citing Papers

JAK inhibition enhances checkpoint blockade immunotherapy in patients with Hodgkin lymphoma
2024 StandoutScience
Depleting myeloid-biased haematopoietic stem cells rejuvenates aged immunity
2024 StandoutNature
4 intermediate papers

Works of Elaine Boyd being referenced

Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders
2005 Standout
Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders
2005 Standout

Author Peers

Author Last Decade Papers Cites
Elaine Boyd 3611 2336 1539 2204 9 4.1k
Clare East 4114 2676 1768 2530 12 4.6k
Nasios Fourouclas 3023 2048 1277 1833 8 3.5k
S Swanton 3047 2194 1274 1841 11 3.6k
Natasha Joan Curtin 2969 1987 1255 1752 6 3.4k
Jean‐Pierre Le Couedic 2373 2107 962 1609 18 3.6k
Ralph Tiedt 2795 2336 1108 2261 33 4.4k
Catherine Lacout 3221 2545 1238 2129 47 4.2k
Judith Staerk 2846 1967 1082 3062 34 4.9k
Gerlinde Wernig 2363 1822 813 1816 34 3.8k
Mike Scott 4254 2994 1723 3003 46 5.8k

All Works

Loading papers...

Rankless by CCL
2026